High EIF4EBP1 expression reflects mTOR pathway activity and cancer cell proliferation and is a biomarker for poor breast cancer prognosis is a research paper published in American Journal of Cancer Research (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA251545-02
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer
National Institutes of Health
Grant: 5R37CA248018-04
Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies
National Institutes of Health
Grant: 5R01CA250412-02
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
NCI NIH HHS
Grant: R37 CA248018
NCI NIH HHS
Grant: P30 CA016056
NCI NIH HHS
Grant: R01 CA251545
NCI NIH HHS
Grant: R01 CA250412
NIBIB NIH HHS
Grant: R01 EB029596
Fields of Study
Keywords